Dublin, Sept. 24, 2024 (GLOBE NEWSWIRE) -- The "Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024" report has been added to ResearchAndMarkets.com's offering.
Co-development Deals in Pharmaceuticals and Biotechnology provides a detailed understanding and analysis of how and why companies enter co-development deals. Fully revised and updated, the report provides details of co-development deals from 2016 to 2024.
The report provides access to co-development deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of co-development deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual co-development contract documents as submitted to the Securities Exchange Commission by companies and their partners.
The report's initial chapters provide an introduction and orientation on co-development dealmaking and business activities. Chapter 1 introduces the report, and Chapter 2 analyzes trends in co-development, discussing the advantages of such deals. Chapter 3 outlines the structure of co-development agreements, while Chapter 4 reviews notable co-development deals since 2016, listing them by value and providing access to contract documents through the SEC when available.
Chapter 5 highlights the top 25 most active co-development dealmakers, with links to the full deal records and contracts, offering easy access via the Current Agreements database. Chapter 6 presents a detailed review of co-development deals organized by company, therapy, technology, and industry type, focusing on agreements signed since 2016.
The comprehensive deal directory includes all co-development deals announced since 2016, accessible through hyperlinks to full records and contract documents where available.
Co-development Deals in Pharmaceuticals and Biotechnology provides the reader with the following key benefits:
- Understand deal trends since 2016
- Browse co-development deals
- Benchmark analysis - identify market value of transactions
- Financials terms
- Directory of deals by company A-Z, therapy focus and technology type
- Leading deals by value
- Most active dealmakers
- Identify assets and deal terms for each transaction
- Access contract documents - insights into deal structures
- Due diligence - assess suitability of your proposed deal terms for partner companies
- Save hundreds of hours of research time
Analyzing contract agreements allows due diligence of:
- What are the rights granted or optioned?
- What rights are granted by the agreement?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are intellectual property rights handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subcontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Key Topics Covered:
Executive Summary
Chapter 1 - Introduction
Chapter 2 - Trends in co-development dealmaking
2.1. Introduction
2.2. Definition of co-development deal
2.3. Trends in co-development deals since 2016
2.3.1. Co-development dealmaking by year, 2016-2024
2.3.2. Co-development dealmaking by phase of development, 2016-2024
2.3.3. Co-development dealmaking by industry sector, 2016-2024
2.3.4. Co-development dealmaking by therapy area, 2016-2024
2.3.5. Co-development dealmaking by technology type, 2016-2024
2.3.6. Co-development dealmaking by most active company, 2016-2024
2.4. Reasons for entering into co-development partnering deals
2.5. The future of co-development deals
Chapter 3 - Overview of co-development deal structure
3.1. Introduction
3.2. Co-development agreement structure
Chapter 4 - Leading co-development deals
4.1. Introduction
4.2. Top co-development deals by value
Chapter 5 - Top 25 most active co-development dealmakers
5.1. Introduction
5.2. Top 25 most active co-development dealmakers
Chapter 6 - Co-development deals including contracts directory
6.1. Introduction
6.2. Co-development deals with contracts 2016-2024
Deal directory
Deal directory - co-development dealmaking by companies A-Z
Deal directory - co-development dealmaking by therapy area
Deal directory - co-development dealmaking by technology type
For more information about this report visit https://www.researchandmarkets.com/r/8vv5jg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
